Oric Pharmaceuticals, Inc. <ORIC.O>: H.C. Wainwright raises target price to $27 from $25
ORIC•Related News
Silicon Motion seeks US$ 160 million termination fee from MaxLinear in arbitration dispute
SIMO•
Bowman Q2 FY26 net income drops to $2.5 million; revenue rises 19.7% to $146.1 million
BWMN•
SharpLink Gaming Q2 Net Income USD -394.3 Million
SBET•
N-Able Q2 revenue slightly beats estimates on AI-powered cybersecurity growth
NABL•
Jazz to buy Actio Biosciences for $820 million upfront, up to $500 million more in milestones
JAZZ•